Go Symbol Lookup
Loading...

Drugs

More

  • INSIGHT-No smoke, plenty of fire fuels e-cigarettes Thursday, 13 Jun 2013 | 7:22 AM ET

    *E-cigarettes sold as less harmful alternative to tobacco. LONDON, June 13- Puffing on slim metal tubes loaded with pale yellow liquid, two London businessmen say they have between their lips a cure for what the U.N. calls "one of the biggest public health threats the world has ever faced".

  • Beshear tells Obama Ky. wants to explore hemp Tuesday, 11 Jun 2013 | 11:00 AM ET

    Beshear sent a letter Friday to President Barack Obama, asking that the Office of Drug Control Policy, U.S. Department of Agriculture and the U.S. attorney general's office work with the Drug Enforcement Administration on the issue.

  • FDA Panel Votes to Ease Avandia Restrictions Thursday, 6 Jun 2013 | 6:39 PM ET
    A bottle and pills of the diabetes drug, Avandia.

    U.S. health advisers voted on Thursday to recommend modifying market restrictions on GlaxoSmithKline's diabetes drug Avandia, the one-time blockbuster at the center of one of the biggest drug controversies in recent years.

  • Pot in the Suburbs and on the Hill  Wednesday, 5 Jun 2013 | 1:08 PM ET

    A Westchester County, New York, woman is accused of running a massive pot operation, reports NBC's Andrea Day. And lobbying efforts to legalize some aspects of the marijuana business are making a pitch to lawmakers, reports CNBC's Hampton Pearson.

  • Women Caught in the 'Weeds' in Westchester  Wednesday, 5 Jun 2013 | 11:16 AM ET

    Andrea Sanderlin of Scarsdale, NY, has been accused of running a massive pot operation, reports NBC's Andrea Day.

  • A hospital epidemiologist and a geneticist at the National Institutes of Health Clinical Center in Bethesda, Md.

    Government officials, drug companies and medical experts, faced with outbreaks of antibiotic-resistant "superbugs", are pushing to speed up the approval of new antibiotics, the NYT reports.

  • Stocks to Shrug Off Blood-Pressure Drug Dispute Friday, 31 May 2013 | 4:29 PM ET

    A dispute within the FDA on whether to put new lung-cancer warnings on ARBs taken by millions of people is unlikely to have any significant effect on the manufacturers stocks.

  • Panel urges tougher US response to trade secret theft Wednesday, 22 May 2013 | 7:19 PM ET

    *Trade secret theft costs $300 billion, 2.1 million jobs. WASHINGTON, May 22- Theft of trade secrets, chiefly by China, costs the U.S. economy $300 billion a year and must be fought with sanctions as tough as those used against terrorism and drug trafficking, an advisory panel said on Wednesday.

  • NEW YORK, May 21- An activist investor in Alere Inc wants the health diagnostics and services company to explore a sale of its drug testing business, which it believes could fetch as much as $2.5 billion and help Alere pay down debt, two people familiar with the matter said on Tuesday.

  • NEW YORK, May 21- An activist investor in Alere Inc wants the health diagnostics and services company to explore a sale of its drug testing business, which it believes could fetch as much as $2.5 billion and help Alere pay down debt, two people familiar with the matter said on Tuesday.

  • Actavis to Buy Warner Chilcott for $8.5 Billion Monday, 20 May 2013 | 8:11 AM ET
    Warner Chilcott Ltd.'s acne treatment Doryx.

    Generic drugmaker Actavis will buy specialty pharmaceuticals company Warner Chilcott in a stock deal valued at about $8.5 billion.

  • Pfizer Inc.'s Viagra medication

    In a first for the drug industry, Pfizer told The Associated Press that the drugmaker will begin selling its popular erectile dysfunction pill Viagra directly to patients on its website.

  • President Barack Obama arrived in Mexico on Thursday for a visit he hopes will draw attention to Mexico's emerging economic might, even as worries about containing drug-trafficking and related violence remain an inescapable subtext.

  • WASHINGTON, April 23- The United States targeted two Lebanese money exchange houses, accusing them on Tuesday of helping launder funds for an international drug trafficking ring and financing the Lebanese militant group Hezbollah.

  • *Embraer to deliver six Super Tucanos and command center. RIO DE JANEIRO, April 9- Brazilian planemaker Embraer SA has sold six Super Tucano light attack planes to Guatemala to bolster its fight against drug trafficking, according to a senior executive.

  • High Court Weighs Drug Companies' Generics Policy Monday, 25 Mar 2013 | 9:49 AM ET

    Federal regulators are pressing the Supreme Court to stop big pharmaceuticals from paying generic drug competitors to delay releasing cheaper versions of brand-name drugs.

  • Roger Parloff, Fortune senior editor, says businesses are sprouting in states like Colorado and Washington, where selling cannabis is now legal.

  • WASHINGTON, March 5- The United States should revive a crackdown on drug trafficking, counterfeiting and other illicit business by North Korea that was succeeding before it was dropped to facilitate a nuclear deal with Pyongyang, architects of that policy said on Tuesday.

  • *FDA rejects Reckitt petition on heroin addiction drug packaging. *FDA approves two generic versions of Reckitt's Suboxone. *FDA refers Reckitt to competition regulator.

  • *Investors eye win for pro-reform party in Italy. LONDON, Feb 25- Italian banks were among the top risers in Europe around midday on Monday as investors started to bet on a centre-left victory a closely-fought general election, seen as crucial to efforts to dig the euro zone out of crisis.

Most Popular Video

Tuesday, 18 Jun 2013 | 4:37 PM ET

DuckDuckGo CEO Gabriel Weinberg says web traffic on his search engine, billed as an alternative to Google that doesn't store your private information, surged 33 percent after the NSA news broke. Weinberg discusses the model of his search engine, and how the company makes money.

Wednesday, 19 Jun 2013 | 6:31 AM ET

John Silvia, Wells Fargo Securities, and Barbara Marcin, Gabelli Dividend Income Fund, discuss whether investors should reconsider allocating their portfolios as the Fed wraps up its two-day policy meeting.

Wednesday, 19 Jun 2013 | 8:53 AM ET

Ken Langone, Invemed Associates chairman and president, called Fed Chairman Ben Bernanke a "lame duck."